- ICH GCP
- Rejestr badań klinicznych w USA
- Badanie kliniczne NCT03952585
Zintensyfikowana radioterapia z chemioterapią (cisplatyną) lub immunoterapią (niwolumab) w leczeniu pacjentów z rakiem jamy ustnej i gardła we wczesnym stadium HPV-dodatnim, u osób niepalących
Randomizowane badanie II/III fazy deintensyfikacji radioterapii u pacjentów z rakiem jamy ustnej i gardła we wczesnym stadium, P16-dodatnim, u osób niepalących
This phase II/III trial studies how well a reduced dose of radiation therapy works with nivolumab compared to cisplatin in treating patients with human papillomavirus (HPV)-positive oropharyngeal cancer that is early in its growth and may not have spread to other parts of the body (early-stage), and is not associated with smoking. Radiation therapy uses high-energy x-rays to kill tumor cells and shrink tumors. Chemotherapy drugs, such as cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial is being done to see if a reduced dose of radiation therapy and nivolumab works as well as standard dose radiation therapy and cisplatin in treating patients with oropharyngeal cancer.
Przegląd badań
Status
Warunki
- Rak płaskonabłonkowy jamy ustnej i gardła
- Rak kolczystokomórkowy
- Basaloid płaskonabłonkowy rak
- Stopień kliniczny I, w którym pośredniczy HPV (p16-dodatni) rak jamy ustnej i gardła AJCC v8
- Stopień kliniczny II, w którym pośredniczy HPV (p16-dodatni) rak jamy ustnej i gardła AJCC v8
- Rak brodawkowaty płaskonabłonkowy
- Patologiczny etap I, w którym pośredniczy HPV (p16-dodatni) rak jamy ustnej i gardła AJCC v8
- Patologiczny etap II, w którym pośredniczy HPV (p16-dodatni) rak jamy ustnej i gardła AJCC v8
Interwencja / Leczenie
- Inny: Quality-of-Life Assessment
- Lek: Cisplatin
- Procedura: Biospecimen Collection
- Procedura: Computed Tomography
- Procedura: Magnetic Resonance Imaging
- Inny: Questionnaire Administration
- Procedura: Positron Emission Tomography
- Biologiczny: Nivolumab
- Promieniowanie: Intensity-Modulated Radiation Therapy
- Inny: Fludeoxyglucose F-18
- Procedura: Biopsy Procedure
- Promieniowanie: Image Guided Radiation Therapy
Szczegółowy opis
PRIMARY OBJECTIVES:
I. To demonstrate non-inferiority in terms of progression-free survival (PFS) of concurrent reduced-dose radiation therapy (RT) with cisplatin or concurrent reduced-dose radiation therapy with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase II) (Arm 2 [concurrent reduced-dose RT with cisplatin] was dropped after interim futility analysis in phase II.) II. To demonstrate non-inferiority in terms of progression-free survival (PFS) of concurrent reduced-dose radiation therapy (RT) with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase II) III. To demonstrate co-primary endpoints of non-inferiority of PFS and superiority of quality of life (QOL) as measured by the MD Anderson Dysphagia Inventory (MDADI) of concurrent reduced-dose radiation with cisplatin or concurrent reduced-dose radiation with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase III) (Arm 2 [concurrent reduced-dose RT with cisplatin] was dropped after interim futility analysis in phase II.) IV. To demonstrate co-primary endpoints of non-inferiority of PFS and superiority of quality of life (QOL) as measured by the MD Anderson Dysphagia Inventory [MDADI] of concurrent reduced-dose radiation with nivolumab to the current standard of care (standard-dose RT with cisplatin). (Phase III)
SECONDARY OBJECTIVES:
I. To compare patterns of failure (local and regional relapse versus distant) and overall survival between the experimental arm and the control arm.
II. To assess long term PFS, overall survival, and toxicity between the experimental arm and the control arm.
III. To determine acute and late toxicity profiles as measured by the Common Terminology Criteria for Adverse Events (CTCAE).
IV. To explore the symptomatic adverse events (AEs) for tolerability of each treatment arm as measured by the Patient-Reported Outcomes (PRO)-CTCAE.
V. To compare changes in patient-reported outcomes (Hearing Handicap Inventory for Adults-Screening [HHIA-S], European Organization for Research and Treatment of Cancer [EORTC]-Quality of Life Questionnaire [QLQ]30) between the experimental arm and the control arm.
VI. To assess the association of fludeoxyglucose F-18 (FDG)-positron emission tomography (PET)/computed tomography (CT) at baseline with locoregional control and PFS.
VII. To estimate the negative predictive value of the 12-14 weeks post-radiation therapy (RT) FDG-PET/CT in terms of locoregional control rates and PFS rates at 1 and 2 years.
EXPLORATORY OBJECTIVES:
I. To collect blood and tissue specimens for future translation research. II. To optimize radiotherapy treatment plan quality assurance methodology for radiotherapy planning and imaging.
III. To compare changes in patient-reported outcomes (European Quality of Life Five Dimension Five Level Scale [EQ-5D-5L]) between the experimental arm and the control arm.
IV. To collect Modified Barium Swallow (MBS) data for future review and analysis.
OUTLINE:
PHASE II: Patients are randomized to 1 of 3 arms.
ARM I: Patients undergo standard dose RT as 70 Gy intensity modulated radiation therapy (IMRT) or image-guided radiation therapy (IGRT) over 6 fractions per week and receive 100 mg/m^2/day cisplatin intravenously (IV) over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive fludeoxyglucose F-18 (FDG) and undergo positron emission tomography (PET)/computed tomography (CT) or CT during screening and during follow up, and undergo magnetic resonance imaging (MRI) during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.
ARM II (CLOSED TO ACCRUAL 03-FEB-2023): Patients undergo reduced dose RT as 60 Gy IMRT or IGRT once daily (QD) over 5 fractions per week and receive 100 mg/m^2/day cisplatin IV over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.
ARM III: Beginning 1 week prior to radiation, patients receive 240 mg fixed dose nivolumab IV over 30 minutes on day 1. Treatment repeats every 2 weeks (14 days) for up to 6 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo reduced dose RT as 60 Gy IMRT or IGRT over 6 fractions per week for 5 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study.
PHASE III: Patients are randomized to Arm I and/or Arm III.
After completion of study treatment, patients are followed up at 12-14 weeks, every 3 months for 2 years, every 6 months for 3 years, and then annually thereafter.
Typ studiów
Zapisy (Rzeczywisty)
Faza
- Faza 2
- Faza 3
Kontakty i lokalizacje
Lokalizacje studiów
-
-
Ontario
-
Toronto, Ontario, Kanada, M5G 2M9
- University Health Network-Princess Margaret Hospital
-
-
-
-
Alabama
-
Birmingham, Alabama, Stany Zjednoczone, 35233
- University of Alabama at Birmingham Cancer Center
-
-
Arizona
-
Gilbert, Arizona, Stany Zjednoczone, 85234
- Banner MD Anderson Cancer Center
-
Tucson, Arizona, Stany Zjednoczone, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Stany Zjednoczone, 85719
- University of Arizona Cancer Center-North Campus
-
-
California
-
Antioch, California, Stany Zjednoczone, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Arroyo Grande, California, Stany Zjednoczone, 93420
- PCR Oncology
-
Auburn, California, Stany Zjednoczone, 95602
- Sutter Auburn Faith Hospital
-
Auburn, California, Stany Zjednoczone, 95603
- Sutter Cancer Centers Radiation Oncology Services-Auburn
-
Bakersfield, California, Stany Zjednoczone, 93301
- AIS Cancer Center at San Joaquin Community Hospital
-
Beverly Hills, California, Stany Zjednoczone, 90211
- Tower Cancer Research Foundation
-
Cameron Park, California, Stany Zjednoczone, 95682
- Sutter Cancer Centers Radiation Oncology Services-Cameron Park
-
Duarte, California, Stany Zjednoczone, 91010
- City of Hope Comprehensive Cancer Center
-
Dublin, California, Stany Zjednoczone, 94568
- Kaiser Permanente Dublin
-
Encinitas, California, Stany Zjednoczone, 92024
- UC San Diego Health System - Encinitas
-
Fremont, California, Stany Zjednoczone, 94538
- Kaiser Permanente-Fremont
-
Fresno, California, Stany Zjednoczone, 93720
- Kaiser Permanente-Fresno
-
Fresno, California, Stany Zjednoczone, 93720
- Fresno Cancer Center
-
Irvine, California, Stany Zjednoczone, 92618
- City of Hope at Irvine Lennar
-
La Jolla, California, Stany Zjednoczone, 92093
- UC San Diego Moores Cancer Center
-
Lancaster, California, Stany Zjednoczone, 93534
- City of Hope Antelope Valley
-
Los Angeles, California, Stany Zjednoczone, 90033
- USC / Norris Comprehensive Cancer Center
-
Los Angeles, California, Stany Zjednoczone, 90048
- Cedars-Sinai Medical Center
-
Los Angeles, California, Stany Zjednoczone, 90033
- Los Angeles General Medical Center
-
Marysville, California, Stany Zjednoczone, 95901
- Fremont - Rideout Cancer Center
-
Modesto, California, Stany Zjednoczone, 95356
- Kaiser Permanente-Modesto
-
Mountain View, California, Stany Zjednoczone, 94040
- Palo Alto Medical Foundation-Camino Division
-
Oakland, California, Stany Zjednoczone, 94611
- Kaiser Permanente-Oakland
-
Oakland, California, Stany Zjednoczone, 94611
- Kaiser Permanente Oakland-Broadway
-
Palo Alto, California, Stany Zjednoczone, 94304
- Stanford Cancer Institute Palo Alto
-
Palo Alto, California, Stany Zjednoczone, 94301
- Palo Alto Medical Foundation Health Care
-
Rancho Cordova, California, Stany Zjednoczone, 95670
- Kaiser Permanente-Rancho Cordova Cancer Center
-
Redwood City, California, Stany Zjednoczone, 94063
- Kaiser Permanente- Marshall Medical Offices
-
Richmond, California, Stany Zjednoczone, 94801
- Kaiser Permanente-Richmond
-
Rohnert Park, California, Stany Zjednoczone, 94928
- Rohnert Park Cancer Center
-
Roseville, California, Stany Zjednoczone, 95678
- The Permanente Medical Group-Roseville Radiation Oncology
-
Roseville, California, Stany Zjednoczone, 95661
- Kaiser Permanente-Roseville
-
Roseville, California, Stany Zjednoczone, 95661
- Sutter Cancer Centers Radiation Oncology Services-Roseville
-
Roseville, California, Stany Zjednoczone, 95661
- Sutter Roseville Medical Center
-
Sacramento, California, Stany Zjednoczone, 95816
- Sutter Medical Center Sacramento
-
Sacramento, California, Stany Zjednoczone, 95817
- University of California Davis Comprehensive Cancer Center
-
Sacramento, California, Stany Zjednoczone, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Stany Zjednoczone, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Stany Zjednoczone, 95823
- South Sacramento Cancer Center
-
San Diego, California, Stany Zjednoczone, 92134
- Naval Medical Center -San Diego
-
San Diego, California, Stany Zjednoczone, 92103
- UC San Diego Medical Center - Hillcrest
-
San Francisco, California, Stany Zjednoczone, 94115
- Kaiser Permanente-San Francisco
-
San Francisco, California, Stany Zjednoczone, 94158
- UCSF Medical Center-Mission Bay
-
San Jose, California, Stany Zjednoczone, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Jose, California, Stany Zjednoczone, 95124
- Stanford Cancer Center South Bay
-
San Leandro, California, Stany Zjednoczone, 94577
- Kaiser Permanente San Leandro
-
San Luis Obispo, California, Stany Zjednoczone, 93401
- Pacific Central Coast Health Center-San Luis Obispo
-
San Rafael, California, Stany Zjednoczone, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, Stany Zjednoczone, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Stany Zjednoczone, 95403
- Kaiser Permanente-Santa Rosa
-
South Pasadena, California, Stany Zjednoczone, 91030
- City of Hope South Pasadena
-
South San Francisco, California, Stany Zjednoczone, 94080
- Kaiser Permanente Cancer Treatment Center
-
South San Francisco, California, Stany Zjednoczone, 94080
- Kaiser Permanente-South San Francisco
-
Stockton, California, Stany Zjednoczone, 95210
- Kaiser Permanente-Stockton
-
Sunnyvale, California, Stany Zjednoczone, 94086
- Palo Alto Medical Foundation-Sunnyvale
-
Torrance, California, Stany Zjednoczone, 90509
- Torrance Memorial Medical Center
-
Torrance, California, Stany Zjednoczone, 90505
- Torrance Memorial Physician Network - Cancer Care
-
Torrance, California, Stany Zjednoczone, 90503
- City of Hope South Bay
-
Upland, California, Stany Zjednoczone, 91786
- City of Hope Upland
-
Vacaville, California, Stany Zjednoczone, 95688
- Kaiser Permanente Medical Center-Vacaville
-
Vallejo, California, Stany Zjednoczone, 94589
- Kaiser Permanente-Vallejo
-
Walnut Creek, California, Stany Zjednoczone, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Stany Zjednoczone, 80045
- Rocky Mountain Regional VA Medical Center
-
Aurora, Colorado, Stany Zjednoczone, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, Stany Zjednoczone, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Colorado Springs, Colorado, Stany Zjednoczone, 80909
- UCHealth Memorial Hospital Central
-
Colorado Springs, Colorado, Stany Zjednoczone, 80907
- Rocky Mountain Cancer Centers-Penrose
-
Colorado Springs, Colorado, Stany Zjednoczone, 80920
- Memorial Hospital North
-
Denver, Colorado, Stany Zjednoczone, 80210
- AdventHealth Porter
-
Fort Collins, Colorado, Stany Zjednoczone, 80524
- Poudre Valley Hospital
-
Fort Collins, Colorado, Stany Zjednoczone, 80528
- Cancer Care and Hematology-Fort Collins
-
Greeley, Colorado, Stany Zjednoczone, 80631
- UCHealth Greeley Hospital
-
Littleton, Colorado, Stany Zjednoczone, 80122
- AdventHealth Littleton
-
Loveland, Colorado, Stany Zjednoczone, 80538
- Medical Center of the Rockies
-
Parker, Colorado, Stany Zjednoczone, 80138
- AdventHealth Parker
-
-
Connecticut
-
Hartford, Connecticut, Stany Zjednoczone, 06102
- Hartford Hospital
-
-
Delaware
-
Newark, Delaware, Stany Zjednoczone, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Stany Zjednoczone, 19713
- Delaware Clinical and Laboratory Physicians PA
-
Newark, Delaware, Stany Zjednoczone, 19713
- Medical Oncology Hematology Consultants PA
-
Newark, Delaware, Stany Zjednoczone, 19718
- Christiana Care Health System-Christiana Hospital
-
-
Florida
-
Coral Gables, Florida, Stany Zjednoczone, 33146
- UM Sylvester Comprehensive Cancer Center at Coral Gables
-
Coral Springs, Florida, Stany Zjednoczone, 33065
- UM Sylvester Comprehensive Cancer Center at Coral Springs
-
Deerfield Beach, Florida, Stany Zjednoczone, 33442
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach
-
Jupiter, Florida, Stany Zjednoczone, 33458
- Jupiter Medical Center
-
Miami, Florida, Stany Zjednoczone, 33136
- University of Miami Miller School of Medicine-Sylvester Cancer Center
-
Miami, Florida, Stany Zjednoczone, 33176
- Miami Cancer Institute
-
Miami, Florida, Stany Zjednoczone, 33176
- UM Sylvester Comprehensive Cancer Center at Kendall
-
Orlando, Florida, Stany Zjednoczone, 32806
- Orlando Health Cancer Institute
-
Tampa, Florida, Stany Zjednoczone, 33612
- Moffitt Cancer Center
-
Tampa, Florida, Stany Zjednoczone, 33607
- Moffitt Cancer Center-International Plaza
-
Tampa, Florida, Stany Zjednoczone, 33612
- Moffitt Cancer Center - McKinley Campus
-
Wesley Chapel, Florida, Stany Zjednoczone, 33544
- Moffitt Cancer Center at Wesley Chapel
-
-
Georgia
-
Atlanta, Georgia, Stany Zjednoczone, 30308
- Emory University Hospital Midtown
-
Atlanta, Georgia, Stany Zjednoczone, 30303
- Grady Health System
-
-
Hawaii
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- Queen's Medical Center
-
Honolulu, Hawaii, Stany Zjednoczone, 96817
- The Cancer Center of Hawaii-Liliha
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- Queen's Cancer Cenrer - POB I
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Stany Zjednoczone, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Stany Zjednoczone, 96817
- Hawaii Cancer Care Inc-Liliha
-
Honolulu, Hawaii, Stany Zjednoczone, 96817
- Kuakini Medical Center
-
Honolulu, Hawaii, Stany Zjednoczone, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Stany Zjednoczone, 96826
- Kapiolani Medical Center for Women and Children
-
Honolulu, Hawaii, Stany Zjednoczone, 96819
- Kaiser Permanente Moanalua Medical Center
-
Lihue, Hawaii, Stany Zjednoczone, 96766
- Wilcox Memorial Hospital and Kauai Medical Clinic
-
‘Aiea, Hawaii, Stany Zjednoczone, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Stany Zjednoczone, 96701
- Pali Momi Medical Center
-
-
Idaho
-
Boise, Idaho, Stany Zjednoczone, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Boise, Idaho, Stany Zjednoczone, 83712
- Saint Luke's Cancer Institute - Boise
-
Caldwell, Idaho, Stany Zjednoczone, 83605
- Saint Alphonsus Cancer Care Center-Caldwell
-
Fruitland, Idaho, Stany Zjednoczone, 83619
- Saint Luke's Cancer Institute - Fruitland
-
Meridian, Idaho, Stany Zjednoczone, 83642
- Saint Luke's Cancer Institute - Meridian
-
Nampa, Idaho, Stany Zjednoczone, 83687
- Saint Alphonsus Cancer Care Center-Nampa
-
Nampa, Idaho, Stany Zjednoczone, 83687
- Saint Luke's Cancer Institute - Nampa
-
Twin Falls, Idaho, Stany Zjednoczone, 83301
- Saint Luke's Cancer Institute - Twin Falls
-
-
Illinois
-
Aurora, Illinois, Stany Zjednoczone, 60504
- Rush-Copley Medical Center
-
Barrington, Illinois, Stany Zjednoczone, 60010
- Advocate Good Shepherd Hospital
-
Bloomington, Illinois, Stany Zjednoczone, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Stany Zjednoczone, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Stany Zjednoczone, 62321
- Illinois CancerCare-Carthage
-
Centralia, Illinois, Stany Zjednoczone, 62801
- Centralia Oncology Clinic
-
Chicago, Illinois, Stany Zjednoczone, 60611
- Northwestern University
-
Chicago, Illinois, Stany Zjednoczone, 60657
- Advocate Illinois Masonic Medical Center
-
Chicago, Illinois, Stany Zjednoczone, 60612
- Rush MD Anderson Cancer Center
-
Crystal Lake, Illinois, Stany Zjednoczone, 60014
- AMG Crystal Lake - Oncology
-
DeKalb, Illinois, Stany Zjednoczone, 60115
- Northwestern Medicine Cancer Center Kishwaukee
-
Decatur, Illinois, Stany Zjednoczone, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Stany Zjednoczone, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Downers Grove, Illinois, Stany Zjednoczone, 60515
- Advocate Good Samaritan Hospital
-
Effingham, Illinois, Stany Zjednoczone, 62401
- Crossroads Cancer Center
-
Elgin, Illinois, Stany Zjednoczone, 60123
- Advocate Sherman Hospital
-
Eureka, Illinois, Stany Zjednoczone, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, Stany Zjednoczone, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, Stany Zjednoczone, 61401
- Western Illinois Cancer Treatment Center
-
Galesburg, Illinois, Stany Zjednoczone, 61401
- Illinois CancerCare-Galesburg
-
Geneva, Illinois, Stany Zjednoczone, 60134
- Northwestern Medicine Cancer Center Delnor
-
Glenview, Illinois, Stany Zjednoczone, 60026
- NorthShore University HealthSystem-Glenbrook Hospital
-
Highland Park, Illinois, Stany Zjednoczone, 60035
- NorthShore University HealthSystem-Highland Park Hospital
-
Kewanee, Illinois, Stany Zjednoczone, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Stany Zjednoczone, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Stany Zjednoczone, 60153
- Loyola University Medical Center
-
O'Fallon, Illinois, Stany Zjednoczone, 62269
- Cancer Care Center of O'Fallon
-
Ottawa, Illinois, Stany Zjednoczone, 61350
- Illinois CancerCare-Ottawa Clinic
-
Park Ridge, Illinois, Stany Zjednoczone, 60068
- Advocate Lutheran General Hospital
-
Pekin, Illinois, Stany Zjednoczone, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Stany Zjednoczone, 61636
- Methodist Medical Center of Illinois
-
Peoria, Illinois, Stany Zjednoczone, 61637
- OSF Saint Francis Medical Center
-
Peoria, Illinois, Stany Zjednoczone, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Stany Zjednoczone, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Stany Zjednoczone, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Stany Zjednoczone, 61114
- UW Health Carbone Cancer Center Rockford
-
Shiloh, Illinois, Stany Zjednoczone, 62269
- Memorial Hospital East
-
Springfield, Illinois, Stany Zjednoczone, 62702
- Southern Illinois University School of Medicine
-
Springfield, Illinois, Stany Zjednoczone, 62702
- Springfield Clinic
-
Springfield, Illinois, Stany Zjednoczone, 62781
- Springfield Memorial Hospital
-
Warrenville, Illinois, Stany Zjednoczone, 60555
- Northwestern Medicine Cancer Center Warrenville
-
Washington, Illinois, Stany Zjednoczone, 61571
- Illinois CancerCare - Washington
-
-
Indiana
-
Carmel, Indiana, Stany Zjednoczone, 46032
- IU Health North Hospital
-
Indianapolis, Indiana, Stany Zjednoczone, 46202
- Indiana University/Melvin and Bren Simon Cancer Center
-
Indianapolis, Indiana, Stany Zjednoczone, 46202
- Sidney and Lois Eskenazi Hospital
-
-
Iowa
-
Clive, Iowa, Stany Zjednoczone, 50325
- Mercy Cancer Center-West Lakes
-
Clive, Iowa, Stany Zjednoczone, 50325
- UI Health Care Mission Cancer and Blood - West Des Moines Clinic
-
Creston, Iowa, Stany Zjednoczone, 50801
- Greater Regional Medical Center
-
Des Moines, Iowa, Stany Zjednoczone, 50309
- Iowa Methodist Medical Center
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- Mercy Medical Center - Des Moines
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- Broadlawns Medical Center
-
Des Moines, Iowa, Stany Zjednoczone, 50316
- Iowa Lutheran Hospital
-
Des Moines, Iowa, Stany Zjednoczone, 50309
- UI Health Care Mission Cancer and Blood - Des Moines Clinic
-
Des Moines, Iowa, Stany Zjednoczone, 50314
- UI Health Care Mission Cancer and Blood - Laurel Clinic
-
West Des Moines, Iowa, Stany Zjednoczone, 50266-7700
- Methodist West Hospital
-
West Des Moines, Iowa, Stany Zjednoczone, 50266
- Mercy Medical Center-West Lakes
-
-
Kansas
-
Kansas City, Kansas, Stany Zjednoczone, 66160
- University of Kansas Cancer Center
-
Lawrence, Kansas, Stany Zjednoczone, 66044
- Lawrence Memorial Hospital
-
Olathe, Kansas, Stany Zjednoczone, 66061
- The University of Kansas Cancer Center - Olathe
-
Overland Park, Kansas, Stany Zjednoczone, 66210
- University of Kansas Cancer Center-Overland Park
-
Salina, Kansas, Stany Zjednoczone, 67401
- Salina Regional Health Center
-
Topeka, Kansas, Stany Zjednoczone, 66606
- University of Kansas Health System Saint Francis Campus
-
Westwood, Kansas, Stany Zjednoczone, 66205
- University of Kansas Hospital-Westwood Cancer Center
-
-
Kentucky
-
Lexington, Kentucky, Stany Zjednoczone, 40536
- University of Kentucky/Markey Cancer Center
-
Louisville, Kentucky, Stany Zjednoczone, 40202
- Norton Hospital Pavilion and Medical Campus
-
Louisville, Kentucky, Stany Zjednoczone, 40202
- The James Graham Brown Cancer Center at University of Louisville
-
Louisville, Kentucky, Stany Zjednoczone, 40241
- Norton Brownsboro Hospital and Medical Campus
-
Louisville, Kentucky, Stany Zjednoczone, 40202
- Jewish Hospital
-
-
Louisiana
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70805
- LSU Health Baton Rouge-North Clinic
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70809
- Louisiana Hematology Oncology Associates LLC
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70809
- Mary Bird Perkins Cancer Center
-
Baton Rouge, Louisiana, Stany Zjednoczone, 70808
- Our Lady of the Lake Physician Group
-
Metairie, Louisiana, Stany Zjednoczone, 70006
- East Jefferson General Hospital
-
-
Maine
-
Bath, Maine, Stany Zjednoczone, 04530
- MaineHealth Coastal Cancer Treatment Center
-
Biddeford, Maine, Stany Zjednoczone, 04005
- MaineHealth Maine Medical Center - Biddeford
-
Portland, Maine, Stany Zjednoczone, 04102
- MaineHealth Maine Medical Center - Portland
-
Rockport, Maine, Stany Zjednoczone, 04856
- Penobscot Bay Medical Center
-
Sanford, Maine, Stany Zjednoczone, 04073
- MaineHealth Cancer Care Center of York County
-
Sanford, Maine, Stany Zjednoczone, 04073
- MaineHealth Cancer Care and IV Therapy - Sanford
-
Scarborough, Maine, Stany Zjednoczone, 04074
- MaineHealth Maine Medical Center- Scarborough
-
South Portland, Maine, Stany Zjednoczone, 04106
- MaineHealth Cancer Care and IV Therapy - South Portland
-
-
Maryland
-
Baltimore, Maryland, Stany Zjednoczone, 21204
- Greater Baltimore Medical Center
-
Baltimore, Maryland, Stany Zjednoczone, 21201
- University of Maryland/Greenebaum Cancer Center
-
Bel Air, Maryland, Stany Zjednoczone, 21014
- UM Upper Chesapeake Medical Center
-
-
Massachusetts
-
Boston, Massachusetts, Stany Zjednoczone, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Stany Zjednoczone, 02118
- Boston Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, Stany Zjednoczone, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Bay City, Michigan, Stany Zjednoczone, 48706
- McLaren Cancer Institute-Bay City
-
Brighton, Michigan, Stany Zjednoczone, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Stany Zjednoczone, 48114
- Trinity Health Medical Center - Brighton
-
Brownstown, Michigan, Stany Zjednoczone, 48183
- Henry Ford Cancer Institute-Downriver
-
Canton, Michigan, Stany Zjednoczone, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Stany Zjednoczone, 48188
- Trinity Health Medical Center - Canton
-
Caro, Michigan, Stany Zjednoczone, 48723
- Caro Cancer Center
-
Chelsea, Michigan, Stany Zjednoczone, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Stany Zjednoczone, 48118
- Chelsea Hospital
-
Clarkston, Michigan, Stany Zjednoczone, 48346
- McLaren Cancer Institute-Clarkston
-
Clinton Township, Michigan, Stany Zjednoczone, 48038
- Henry Ford Macomb Hospital-Clinton Township
-
Dearborn, Michigan, Stany Zjednoczone, 48126
- Henry Ford Medical Center-Fairlane
-
Detroit, Michigan, Stany Zjednoczone, 48202
- Henry Ford Hospital
-
Detroit, Michigan, Stany Zjednoczone, 48201
- Wayne State University/Karmanos Cancer Institute
-
Farmington Hills, Michigan, Stany Zjednoczone, 48334
- Weisberg Cancer Treatment Center
-
Flint, Michigan, Stany Zjednoczone, 48532
- McLaren Cancer Institute-Flint
-
Flint, Michigan, Stany Zjednoczone, 48532
- Singh and Arora Hematology Oncology PC
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Grand Rapids, Michigan, Stany Zjednoczone, 49503
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
-
Lansing, Michigan, Stany Zjednoczone, 48912
- Mid-Michigan Physicians-Lansing
-
Lansing, Michigan, Stany Zjednoczone, 48910
- Karmanos Cancer Institute at McLaren Greater Lansing
-
Lansing, Michigan, Stany Zjednoczone, 48912
- University of Michigan Health - Sparrow Lansing
-
Lapeer, Michigan, Stany Zjednoczone, 48446
- McLaren Cancer Institute-Lapeer Region
-
Livonia, Michigan, Stany Zjednoczone, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Marlette, Michigan, Stany Zjednoczone, 48453
- Saint Mary's Oncology/Hematology Associates of Marlette
-
Mount Clemens, Michigan, Stany Zjednoczone, 48043
- McLaren Cancer Institute-Macomb
-
Niles, Michigan, Stany Zjednoczone, 49120
- Corewell Health Lakeland Hospitals - Niles Hospital
-
Novi, Michigan, Stany Zjednoczone, 48377
- Henry Ford Medical Center-Columbus
-
Petoskey, Michigan, Stany Zjednoczone, 49770
- McLaren Cancer Institute-Northern Michigan
-
Port Huron, Michigan, Stany Zjednoczone, 48060
- McLaren-Port Huron
-
Saginaw, Michigan, Stany Zjednoczone, 48604
- Oncology Hematology Associates of Saginaw Valley PC
-
Saginaw, Michigan, Stany Zjednoczone, 48601
- MyMichigan Medical Center Saginaw
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center
-
Saint Joseph, Michigan, Stany Zjednoczone, 49085
- Corewell Health Lakeland Hospitals - Saint Joseph Hospital
-
Shelby, Michigan, Stany Zjednoczone, 48315
- Henry Ford Macomb Health Center - Shelby Township
-
Tawas City, Michigan, Stany Zjednoczone, 48764
- MyMichigan Medical Center Tawas
-
West Bloomfield, Michigan, Stany Zjednoczone, 48322
- Henry Ford West Bloomfield Hospital
-
West Branch, Michigan, Stany Zjednoczone, 48661
- Saint Mary's Oncology/Hematology Associates of West Branch
-
Wyoming, Michigan, Stany Zjednoczone, 49519
- University of Michigan Health - West
-
Ypsilanti, Michigan, Stany Zjednoczone, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Bemidji, Minnesota, Stany Zjednoczone, 56601
- Sanford Joe Lueken Cancer Center
-
Brainerd, Minnesota, Stany Zjednoczone, 56401
- Essentia Health Saint Joseph's Medical Center
-
Deer River, Minnesota, Stany Zjednoczone, 56636
- Essentia Health - Deer River Clinic
-
Duluth, Minnesota, Stany Zjednoczone, 55805
- Essentia Health Cancer Center
-
Duluth, Minnesota, Stany Zjednoczone, 55805
- Essentia Health Saint Mary's Medical Center
-
Duluth, Minnesota, Stany Zjednoczone, 55805
- Miller-Dwan Hospital
-
Hibbing, Minnesota, Stany Zjednoczone, 55746
- Essentia Health Hibbing Clinic
-
Saint Cloud, Minnesota, Stany Zjednoczone, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Sandstone, Minnesota, Stany Zjednoczone, 55072
- Essentia Health Sandstone
-
Virginia, Minnesota, Stany Zjednoczone, 55792
- Essentia Health Virginia Clinic
-
-
Missouri
-
Cape Girardeau, Missouri, Stany Zjednoczone, 63703
- Saint Francis Medical Center
-
City of Saint Peters, Missouri, Stany Zjednoczone, 63376
- Siteman Cancer Center at Saint Peters Hospital
-
Creve Coeur, Missouri, Stany Zjednoczone, 63141
- Siteman Cancer Center at West County Hospital
-
Farmington, Missouri, Stany Zjednoczone, 63640
- Parkland Health Center - Farmington
-
Joplin, Missouri, Stany Zjednoczone, 64804
- Freeman Health System
-
Kansas City, Missouri, Stany Zjednoczone, 64154
- University of Kansas Cancer Center - North
-
Lee's Summit, Missouri, Stany Zjednoczone, 64064
- University of Kansas Cancer Center - Lee's Summit
-
North Kansas City, Missouri, Stany Zjednoczone, 64116
- University of Kansas Cancer Center at North Kansas City Hospital
-
Rolla, Missouri, Stany Zjednoczone, 65401
- Mercy Clinic-Rolla-Cancer and Hematology
-
Rolla, Missouri, Stany Zjednoczone, 65401
- Phelps Health Delbert Day Cancer Institute
-
Springfield, Missouri, Stany Zjednoczone, 65804
- Mercy Hospital Springfield
-
St Louis, Missouri, Stany Zjednoczone, 63110
- Washington University School of Medicine
-
St Louis, Missouri, Stany Zjednoczone, 63129
- Siteman Cancer Center-South County
-
-
Montana
-
Bozeman, Montana, Stany Zjednoczone, 59715
- Bozeman Health Deaconess Hospital
-
Great Falls, Montana, Stany Zjednoczone, 59405
- Benefis Sletten Cancer Institute
-
-
Nebraska
-
Kearney, Nebraska, Stany Zjednoczone, 68847
- CHI Health Good Samaritan
-
Omaha, Nebraska, Stany Zjednoczone, 68198
- University of Nebraska Medical Center
-
-
Nevada
-
Reno, Nevada, Stany Zjednoczone, 89502
- Renown Regional Medical Center
-
-
New Hampshire
-
Lebanon, New Hampshire, Stany Zjednoczone, 03756
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center
-
-
New Jersey
-
New Brunswick, New Jersey, Stany Zjednoczone, 08903
- Rutgers Cancer Institute of New Jersey
-
Toms River, New Jersey, Stany Zjednoczone, 08755
- Community Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, Stany Zjednoczone, 87109
- New Mexico Oncology Hematology Consultants
-
Albuquerque, New Mexico, Stany Zjednoczone, 87106
- University of New Mexico Cancer Center
-
-
New York
-
Canandaigua, New York, Stany Zjednoczone, 14424
- Sands Cancer Center
-
Dansville, New York, Stany Zjednoczone, 14437
- Noyes Memorial Hospital/Myers Cancer Center
-
Oswego, New York, Stany Zjednoczone, 13126
- Upstate Cancer Center at Oswego
-
Rochester, New York, Stany Zjednoczone, 14642
- University of Rochester
-
Rochester, New York, Stany Zjednoczone, 14620
- Highland Hospital
-
Stony Brook, New York, Stany Zjednoczone, 11794
- Stony Brook University Medical Center
-
Syracuse, New York, Stany Zjednoczone, 13210
- State University of New York Upstate Medical University
-
Syracuse, New York, Stany Zjednoczone, 13215
- SUNY Upstate Medical Center-Community Campus
-
Verona, New York, Stany Zjednoczone, 13478
- Upstate Cancer Center at Verona
-
Webster, New York, Stany Zjednoczone, 14580
- Wilmot Cancer Institute at Webster
-
-
North Carolina
-
Charlotte, North Carolina, Stany Zjednoczone, 28203
- Carolinas Medical Center/Levine Cancer Institute
-
Charlotte, North Carolina, Stany Zjednoczone, 28204
- Novant Health Presbyterian Medical Center
-
Charlotte, North Carolina, Stany Zjednoczone, 28210
- Atrium Health Pineville/LCI-Pineville
-
Charlotte, North Carolina, Stany Zjednoczone, 28262
- Atrium Health University City/LCI-University
-
Charlotte, North Carolina, Stany Zjednoczone, 28277
- Levine Cancer Institute-Ballantyne
-
Clemmons, North Carolina, Stany Zjednoczone, 27012
- Wake Forest University at Clemmons
-
Concord, North Carolina, Stany Zjednoczone, 28025
- Atrium Health Cabarrus/LCI-Concord
-
Gastonia, North Carolina, Stany Zjednoczone, 28054
- CaroMont Regional Medical Center
-
Greenville, North Carolina, Stany Zjednoczone, 27834
- East Carolina University
-
Huntersville, North Carolina, Stany Zjednoczone, 28078
- Novant Health Cancer Institute - Huntersville
-
Huntersville, North Carolina, Stany Zjednoczone, 28078
- Novant Health Presbyterian Medical Center Huntersville
-
Kernersville, North Carolina, Stany Zjednoczone, 27284
- Novant Health Cancer Institute - Kernersville
-
Matthews, North Carolina, Stany Zjednoczone, 28105
- Novant Health Cancer Institute - Matthews
-
Monroe, North Carolina, Stany Zjednoczone, 28112
- Atrium Health Union/LCI-Union
-
Mooresville, North Carolina, Stany Zjednoczone, 28117
- Novant Health Cancer Institute - Mooresville
-
Mount Airy, North Carolina, Stany Zjednoczone, 27030
- Novant Health Cancer Institute - Mount Airy
-
North Wilkesboro, North Carolina, Stany Zjednoczone, 28659
- Novant Health Cancer Institute - Wilkesboro
-
Pinehurst, North Carolina, Stany Zjednoczone, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Salisbury, North Carolina, Stany Zjednoczone, 28144
- Novant Health Cancer Institute - Rowan
-
Statesville, North Carolina, Stany Zjednoczone, 28625
- Novant Health Cancer Institute - Statesville
-
Statesville, North Carolina, Stany Zjednoczone, 28677
- Wake Forest Baptist Health - Hematology Oncology - Statesville
-
Supply, North Carolina, Stany Zjednoczone, 28462
- Novant Cancer Institute Radiation Oncology - Supply
-
Thomasville, North Carolina, Stany Zjednoczone, 27360
- Novant Health Cancer Institute - Thomasville
-
Wilkesboro, North Carolina, Stany Zjednoczone, 28659
- Wake Forest Baptist Health - Wilkes Medical Center
-
Wilmington, North Carolina, Stany Zjednoczone, 28401
- Novant Health New Hanover Regional Medical Center
-
Wilmington, North Carolina, Stany Zjednoczone, 28401
- Novant Health Cancer Institute Radiation Oncology - Wilmington
-
Winston-Salem, North Carolina, Stany Zjednoczone, 27157
- Wake Forest University Health Sciences
-
Winston-Salem, North Carolina, Stany Zjednoczone, 27103
- Novant Health Forsyth Medical Center
-
-
North Dakota
-
Bismarck, North Dakota, Stany Zjednoczone, 58501
- Sanford Bismarck Medical Center
-
Fargo, North Dakota, Stany Zjednoczone, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Stany Zjednoczone, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Akron, Ohio, Stany Zjednoczone, 44304
- Summa Health System - Akron Campus
-
Avon, Ohio, Stany Zjednoczone, 44011
- UH Seidman Cancer Center at UH Avon Health Center
-
Barberton, Ohio, Stany Zjednoczone, 44203
- Summa Health System - Barberton Campus
-
Chardon, Ohio, Stany Zjednoczone, 44024
- Geauga Hospital
-
Cincinnati, Ohio, Stany Zjednoczone, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cleveland, Ohio, Stany Zjednoczone, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Stany Zjednoczone, 44109
- MetroHealth Medical Center
-
Cleveland, Ohio, Stany Zjednoczone, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Stany Zjednoczone, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Stany Zjednoczone, 43210
- Ohio State University Comprehensive Cancer Center
-
Mansfield, Ohio, Stany Zjednoczone, 44906
- Cleveland Clinic Cancer Center Mansfield
-
Mayfield Heights, Ohio, Stany Zjednoczone, 44124
- Hillcrest Hospital Cancer Center
-
Medina, Ohio, Stany Zjednoczone, 44256
- Summa Health Medina Medical Center
-
Mentor, Ohio, Stany Zjednoczone, 44060
- UH Seidman Cancer Center at Lake Health Mentor Campus
-
Middleburg Heights, Ohio, Stany Zjednoczone, 44130
- UH Seidman Cancer Center at Southwest General Hospital
-
Parma, Ohio, Stany Zjednoczone, 44129
- University Hospitals Parma Medical Center
-
Perrysburg, Ohio, Stany Zjednoczone, 43551
- Mercy Health - Perrysburg Hospital
-
Ravenna, Ohio, Stany Zjednoczone, 44266
- University Hospitals Portage Medical Center
-
Sandusky, Ohio, Stany Zjednoczone, 44870
- North Coast Cancer Care
-
Strongsville, Ohio, Stany Zjednoczone, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Sylvania, Ohio, Stany Zjednoczone, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Stany Zjednoczone, 43623
- Mercy Health - Saint Anne Hospital
-
Toledo, Ohio, Stany Zjednoczone, 43608
- Mercy Health - Saint Vincent Hospital
-
Toledo, Ohio, Stany Zjednoczone, 43623
- Mercy Health Sylvania Radiation Oncology Center
-
West Chester, Ohio, Stany Zjednoczone, 45069
- University of Cincinnati Cancer Center-West Chester
-
Westlake, Ohio, Stany Zjednoczone, 44145
- UH Seidman Cancer Center at Saint John Medical Center
-
Westlake, Ohio, Stany Zjednoczone, 44145
- UHHS-Westlake Medical Center
-
Wooster, Ohio, Stany Zjednoczone, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
-
Oklahoma
-
Oklahoma City, Oklahoma, Stany Zjednoczone, 73104
- University of Oklahoma Health Sciences Center
-
-
Oregon
-
Clackamas, Oregon, Stany Zjednoczone, 97015
- Clackamas Radiation Oncology Center
-
Clackamas, Oregon, Stany Zjednoczone, 97015
- Providence Cancer Institute Clackamas Clinic
-
Newberg, Oregon, Stany Zjednoczone, 97132
- Providence Newberg Medical Center
-
Oregon City, Oregon, Stany Zjednoczone, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Stany Zjednoczone, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Stany Zjednoczone, 97225
- Providence Saint Vincent Medical Center
-
Portland, Oregon, Stany Zjednoczone, 97227
- Kaiser Permanente Northwest
-
-
Pennsylvania
-
Allentown, Pennsylvania, Stany Zjednoczone, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Altoona, Pennsylvania, Stany Zjednoczone, 16601
- UPMC Altoona
-
Beaver, Pennsylvania, Stany Zjednoczone, 15009
- UPMC-Heritage Valley Health System Beaver
-
Carlisle, Pennsylvania, Stany Zjednoczone, 17015
- Carlisle Regional Cancer Center
-
Chadds Ford, Pennsylvania, Stany Zjednoczone, 19317
- Christiana Care Health System-Concord Health Center
-
Chambersburg, Pennsylvania, Stany Zjednoczone, 17201
- Chambersburg Hospital
-
Danville, Pennsylvania, Stany Zjednoczone, 17822
- Geisinger Medical Center
-
East Norriton, Pennsylvania, Stany Zjednoczone, 19401
- Fox Chase Cancer Center - East Norriton Hospital Outpatient Center
-
Ephrata, Pennsylvania, Stany Zjednoczone, 17522
- Ephrata Cancer Center
-
Erie, Pennsylvania, Stany Zjednoczone, 16505
- UPMC Hillman Cancer Center Erie
-
Farrell, Pennsylvania, Stany Zjednoczone, 16121
- UPMC Cancer Center at UPMC Horizon
-
Furlong, Pennsylvania, Stany Zjednoczone, 18925
- Fox Chase Cancer Center Buckingham
-
Gettysburg, Pennsylvania, Stany Zjednoczone, 17325
- Adams Cancer Center
-
Greensburg, Pennsylvania, Stany Zjednoczone, 15601
- UPMC Cancer Centers - Arnold Palmer Pavilion
-
Harrisburg, Pennsylvania, Stany Zjednoczone, 17109
- UPMC Pinnacle Cancer Center/Community Osteopathic Campus
-
Hershey, Pennsylvania, Stany Zjednoczone, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Johnstown, Pennsylvania, Stany Zjednoczone, 15901
- UPMC-Johnstown/John P. Murtha Regional Cancer Center
-
Lewisburg, Pennsylvania, Stany Zjednoczone, 17837
- Geisinger Medical Oncology-Lewisburg
-
Lewistown, Pennsylvania, Stany Zjednoczone, 17044
- Lewistown Hospital
-
McKeesport, Pennsylvania, Stany Zjednoczone, 15132
- UPMC Cancer Center at UPMC McKeesport
-
Mechanicsburg, Pennsylvania, Stany Zjednoczone, 17050
- UPMC Hillman Cancer Center at Rocco And Nancy Ortenzio Cancer Pavilion
-
Monroeville, Pennsylvania, Stany Zjednoczone, 15146
- Forbes Hospital
-
Monroeville, Pennsylvania, Stany Zjednoczone, 15146
- UPMC Cancer Center - Monroeville
-
Moon Township, Pennsylvania, Stany Zjednoczone, 15108
- UPMC Hillman Cancer Center in Coraopolis
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19107
- Thomas Jefferson University Hospital
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19114
- Jefferson Torresdale Hospital
-
Philadelphia, Pennsylvania, Stany Zjednoczone, 19140
- Temple University Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15212
- Allegheny General Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15213
- UPMC-Magee Womens Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15232
- UPMC-Shadyside Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15215
- UPMC-Saint Margaret
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15237
- UPMC-Passavant Hospital
-
Pittsburgh, Pennsylvania, Stany Zjednoczone, 15243
- UPMC-Saint Clair Hospital Cancer Center
-
Pottsville, Pennsylvania, Stany Zjednoczone, 17901
- Geisinger Cancer Services-Pottsville
-
Seneca, Pennsylvania, Stany Zjednoczone, 16346
- UPMC Cancer Center at UPMC Northwest
-
Uniontown, Pennsylvania, Stany Zjednoczone, 15401
- UPMC Uniontown Hospital Radiation Oncology
-
Washington, Pennsylvania, Stany Zjednoczone, 15301
- UPMC Washington Hospital Radiation Oncology
-
West Reading, Pennsylvania, Stany Zjednoczone, 19611
- Reading Hospital
-
Wexford, Pennsylvania, Stany Zjednoczone, 15090
- Wexford Health and Wellness Pavilion
-
Wilkes-Barre, Pennsylvania, Stany Zjednoczone, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
Williamsport, Pennsylvania, Stany Zjednoczone, 17754
- Divine Providence Hospital
-
Willow Grove, Pennsylvania, Stany Zjednoczone, 19090
- Asplundh Cancer Pavilion
-
York, Pennsylvania, Stany Zjednoczone, 17403
- WellSpan Health-York Cancer Center
-
York, Pennsylvania, Stany Zjednoczone, 17403
- WellSpan Health-York Hospital
-
York, Pennsylvania, Stany Zjednoczone, 17408
- UPMC Memorial
-
-
South Carolina
-
Charleston, South Carolina, Stany Zjednoczone, 29425
- Medical University of South Carolina
-
Gaffney, South Carolina, Stany Zjednoczone, 29341
- Gibbs Cancer Center-Gaffney
-
Georgetown, South Carolina, Stany Zjednoczone, 29440
- Tidelands Georgetown Memorial Hospital
-
Greenville, South Carolina, Stany Zjednoczone, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Stany Zjednoczone, 29607
- Saint Francis Cancer Center
-
Greenville, South Carolina, Stany Zjednoczone, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Stany Zjednoczone, 29601
- Saint Francis Hospital
-
Greer, South Carolina, Stany Zjednoczone, 29650
- Prisma Health Cancer Institute - Greer
-
Greer, South Carolina, Stany Zjednoczone, 29651
- Gibbs Cancer Center-Pelham
-
Rock Hill, South Carolina, Stany Zjednoczone, 29732
- Levine Cancer Institute-Rock Hill
-
Rock Hill, South Carolina, Stany Zjednoczone, 29730
- Rock Hill Radiation Therapy Center
-
Seneca, South Carolina, Stany Zjednoczone, 29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg, South Carolina, Stany Zjednoczone, 29303
- Spartanburg Medical Center
-
Union, South Carolina, Stany Zjednoczone, 29379
- SMC Center for Hematology Oncology Union
-
-
South Dakota
-
Sioux Falls, South Dakota, Stany Zjednoczone, 57105
- Avera Cancer Institute
-
Sioux Falls, South Dakota, Stany Zjednoczone, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Stany Zjednoczone, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Germantown, Tennessee, Stany Zjednoczone, 38138
- The West Clinic - Wolf River
-
Knoxville, Tennessee, Stany Zjednoczone, 37920
- University of Tennessee - Knoxville
-
Nashville, Tennessee, Stany Zjednoczone, 37232
- Vanderbilt University/Ingram Cancer Center
-
-
Texas
-
Amarillo, Texas, Stany Zjednoczone, 79106
- The Don and Sybil Harrington Cancer Center
-
-
Utah
-
American Fork, Utah, Stany Zjednoczone, 84003
- American Fork Hospital / Huntsman Intermountain Cancer Center
-
Farmington, Utah, Stany Zjednoczone, 84025
- Farmington Health Center
-
Logan, Utah, Stany Zjednoczone, 84321
- Logan Regional Hospital
-
Murray, Utah, Stany Zjednoczone, 84107
- Intermountain Medical Center
-
Ogden, Utah, Stany Zjednoczone, 84403
- McKay-Dee Hospital Center
-
Provo, Utah, Stany Zjednoczone, 84604
- Utah Valley Regional Medical Center
-
Riverton, Utah, Stany Zjednoczone, 84065
- Riverton Hospital
-
Salt Lake City, Utah, Stany Zjednoczone, 84112
- Huntsman Cancer Institute/University of Utah
-
Salt Lake City, Utah, Stany Zjednoczone, 84106
- Utah Cancer Specialists-Salt Lake City
-
Salt Lake City, Utah, Stany Zjednoczone, 84143
- LDS Hospital
-
St. George, Utah, Stany Zjednoczone, 84770
- Saint George Regional Medical Center
-
-
Vermont
-
Saint Johnsbury, Vermont, Stany Zjednoczone, 05819
- Dartmouth Cancer Center - North
-
-
Virginia
-
Fairfax, Virginia, Stany Zjednoczone, 22031
- Inova Schar Cancer Institute
-
Fairfax, Virginia, Stany Zjednoczone, 22033
- Inova Fair Oaks Hospital
-
Portsmouth, Virginia, Stany Zjednoczone, 23708-2197
- Naval Medical Center - Portsmouth
-
Richmond, Virginia, Stany Zjednoczone, 23235
- VCU Massey Cancer Center at Stony Point
-
Richmond, Virginia, Stany Zjednoczone, 23298
- VCU Massey Comprehensive Cancer Center
-
-
Washington
-
Renton, Washington, Stany Zjednoczone, 98055
- Valley Medical Center
-
Seattle, Washington, Stany Zjednoczone, 98107
- Swedish Medical Center-Ballard Campus
-
Seattle, Washington, Stany Zjednoczone, 98122
- Swedish Medical Center-First Hill
-
Walla Walla, Washington, Stany Zjednoczone, 99362
- Providence Saint Mary Regional Cancer Center
-
-
Wisconsin
-
Antigo, Wisconsin, Stany Zjednoczone, 54409
- Aspirus Cancer Care-Antigo-Volm Cancer Center
-
Appleton, Wisconsin, Stany Zjednoczone, 54915
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton
-
Ashland, Wisconsin, Stany Zjednoczone, 54806
- Duluth Clinic Ashland
-
Ashland, Wisconsin, Stany Zjednoczone, 54806
- Northwest Wisconsin Cancer Center
-
Brookfield, Wisconsin, Stany Zjednoczone, 53045
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield
-
Burlington, Wisconsin, Stany Zjednoczone, 53105
- Aurora Cancer Care-Southern Lakes VLCC
-
Chilton, Wisconsin, Stany Zjednoczone, 53014
- Ascension Calumet Hospital-Chilton
-
Eau Claire, Wisconsin, Stany Zjednoczone, 54701
- HSHS Sacred Heart Hospital
-
Franklin, Wisconsin, Stany Zjednoczone, 53132
- Ascension Southeast Wisconsin Hospital - Franklin
-
Franklin, Wisconsin, Stany Zjednoczone, 53132
- Reiman Cancer Center-Ascension Wisconsin Health Center-Rawson
-
Germantown, Wisconsin, Stany Zjednoczone, 53022
- Aurora Health Care Germantown Health Center
-
Grafton, Wisconsin, Stany Zjednoczone, 53024
- Aurora Cancer Care-Grafton
-
Green Bay, Wisconsin, Stany Zjednoczone, 54311
- Aurora BayCare Medical Center
-
Green Bay, Wisconsin, Stany Zjednoczone, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Stany Zjednoczone, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Hayward, Wisconsin, Stany Zjednoczone, 54843
- Essentia Health-Hayward Clinic
-
Johnson Creek, Wisconsin, Stany Zjednoczone, 53038
- University of Wisconsin Carbone Cancer Center - Johnson Creek
-
Kenosha, Wisconsin, Stany Zjednoczone, 53142
- Aurora Cancer Care-Kenosha South
-
La Crosse, Wisconsin, Stany Zjednoczone, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Stany Zjednoczone, 53792
- University of Wisconsin Carbone Cancer Center - University Hospital
-
Marinette, Wisconsin, Stany Zjednoczone, 54143
- Aurora Bay Area Medical Group-Marinette
-
Menomonee Falls, Wisconsin, Stany Zjednoczone, 53051
- Froedtert Menomonee Falls Hospital
-
Mequon, Wisconsin, Stany Zjednoczone, 53097
- Ascension Columbia Saint Mary's Hospital-Ozaukee Campus-Mequon
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53209
- Aurora Cancer Care-Milwaukee
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53215
- Aurora Saint Luke's Medical Center
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53233
- Aurora Sinai Medical Center
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53210
- Ascension Southeast Wisconsin Hospital-Saint Joseph-Milwaukee
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53211
- Ascension Columbia Saint Mary's Hospital-Milwaukee Campus
-
Milwaukee, Wisconsin, Stany Zjednoczone, 53215
- Ascension Saint Francis Hospital-Milwaukee
-
Oshkosh, Wisconsin, Stany Zjednoczone, 54904
- Vince Lombardi Cancer Clinic - Oshkosh
-
Oshkosh, Wisconsin, Stany Zjednoczone, 54904
- Ascension Northeast Wisconsin-Mercy Hospital-Oshkosh
-
Racine, Wisconsin, Stany Zjednoczone, 53406
- Aurora Cancer Care-Racine
-
Racine, Wisconsin, Stany Zjednoczone, 53405
- Ascension All Saints Hospital-Spring Street-Racine
-
Rhinelander, Wisconsin, Stany Zjednoczone, 54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Sheboygan, Wisconsin, Stany Zjednoczone, 53081
- Vince Lombardi Cancer Clinic-Sheboygan
-
Spooner, Wisconsin, Stany Zjednoczone, 54801
- Essentia Health-Spooner Clinic
-
Stevens Point, Wisconsin, Stany Zjednoczone, 54481
- Aspirus Cancer Care - Stevens Point
-
Summit, Wisconsin, Stany Zjednoczone, 53066
- Aurora Medical Center in Summit
-
Superior, Wisconsin, Stany Zjednoczone, 54880
- Essentia Health Saint Mary's Hospital - Superior
-
Two Rivers, Wisconsin, Stany Zjednoczone, 54241
- Vince Lombardi Cancer Clinic-Two Rivers
-
Wausau, Wisconsin, Stany Zjednoczone, 54401
- Aspirus Cancer Care-Wausau
-
Wauwatosa, Wisconsin, Stany Zjednoczone, 53226
- Aurora Cancer Care-Milwaukee West
-
Wauwatosa, Wisconsin, Stany Zjednoczone, 53226
- Ascension Southeast Wisconsin Hospital-Mayfair Road-Wauwatosa
-
West Allis, Wisconsin, Stany Zjednoczone, 53227
- Aurora West Allis Medical Center
-
West Bend, Wisconsin, Stany Zjednoczone, 53095
- Froedtert West Bend Hospital/Kraemer Cancer Center
-
Wisconsin Rapids, Wisconsin, Stany Zjednoczone, 54494
- Aspirus Cancer Care - Wisconsin Rapids
-
-
Kryteria uczestnictwa
Kryteria kwalifikacji
Wiek uprawniający do nauki
Akceptuje zdrowych ochotników
Płeć kwalifikująca się do nauki
Opis
Inclusion Criteria:
-
Pathologically (histologically or cytologically) proven diagnosis of squamous cell carcinoma (including the histological variants papillary squamous cell carcinoma and basaloid squamous cell carcinoma but not neuroendocrine phenotype) of the oropharynx (tonsil, base of tongue, soft palate, or oropharyngeal walls); cytologic diagnosis from a cervical lymph node is sufficient in the presence of clinical evidence of a primary tumor in the oropharynx. Clinical evidence should be documented, may consist of palpation, imaging, or endoscopic evaluation, and should be sufficient to estimate the size of the primary (for T stage)
-
Patients must have clinically or radiographically evident measurable disease at the primary site or at nodal stations. Simple tonsillectomy or local excision of the primary without removal of nodal disease is permitted, as is excision removing gross nodal disease but with intact primary site. Limited neck dissections retrieving =< 4 nodes are permitted and considered as non-therapeutic nodal excisions
-
P16-positive based on local site immunohistochemical tissue staining (defined as greater than 70% strong diffuse nuclear or nuclear and cytoplasmic staining of tumor cells). Fine needle aspiration (FNA) biopsy specimens may be used as the sole diagnostic tissue. Centers are encouraged to contact the pathology chair for clarification
- Note: Institutions must screen patients, whose tumors must be p16-positive by immunohistochemistry (IHC) in order to be eligible for the trial using a Clinical Laboratory Improvement Amendments (CLIA)-certified laboratory. A rigorous laboratory accreditation process similar to the United States (U.S.) CLIA certification, such as the provincial accreditation status offered by the Ontario Laboratory Accreditation (OLA) Program in Canada, the College of American Pathologists (CAP), or an equivalent accreditation in other countries, is acceptable. The p16-positive results must be reported on the pathology report being submitted
- Note: If p16 result is equivocal, positive HPV deoxyribonucleic acid (DNA) test of tumor specimen is acceptable and fulfills the eligibility criteria
-
Clinical stage T1-2, N1, M0 (American Joint Committee on Cancer [AJCC], 8th edition [ed.]) or T3, N0-N1, M0 (AJCC, 8th ed.) including no distant metastases based on the following diagnostic workup:
-
General history and physical examination within 56 days prior to registration;
-
Exam with laryngopharyngoscopy (mirror or in office direct procedure acceptable) within 70 days prior to registration;
-
One of the following imaging studies is required within 56 days prior to registration:
- FDG-PET/CT of the neck and chest (with or without contrast); FDG-PET/CT scan is strongly preferred and highly recommended to be used for eligibility OR
- Chest CT (with or without contrast)
-
One of the following imaging studies is required within 28 days prior to registration:
- A diagnostic CT scan of neck (with contrast and of diagnostic quality) OR
- An magnetic resonance imaging (MRI) of the neck (with contrast and of diagnostic quality)
- Note: A diagnostic quality CT or MRI with contrast or FDG-PET/CT scan of neck performed for the purposes of radiation planning may serve as both staging and planning tools
-
-
Patients must provide their personal smoking history prior to registration. The lifetime cumulative history cannot exceed 10 pack-years. The following formula is used to calculate the pack-years during the periods of smoking in the patient's life; the cumulative total of the number of pack-years during each period of active smoking is the lifetime cumulative history
- Number of pack-years = [Frequency of smoking (number of cigarettes per day) x duration of cigarette smoking (years)] / 20
- Note: Twenty cigarettes is considered equivalent to one pack. The effect of non-cigarette tobacco products on the survival of patients with p16-positive oropharyngeal cancers is undefined. While there are reportedly increased risks of head and neck cancer associated with sustained heavy cigar and pipe use (Wyss 2013), such sustained use of non-cigarette products is unusual and does not appear to convey added risk with synchronous cigarette smoking. Cigar and pipe tobacco consumption is therefore not included in calculating the lifetime pack-years. Marijuana consumption is likewise not considered in this calculation. There is no clear scientific evidence regarding the role of chewing tobacco-containing products in this disease, although this is possibly more concerning given the proximity of the oral cavity and oropharynx. In any case, investigators are discouraged from enrolling patients with a history of very sustained use (such as several years or more) of non-cigarette tobacco products alone
-
Zubrod performance status of 0-1 within 14 days prior to registration
-
Age >= 18
-
Absolute neutrophil count >= 1,500/mcL (within 14 days prior to registration)
-
Platelets >= 100,000/mcL (within 14 days prior to registration)
-
Hemoglobin >= 8.0 g/dL (within 14 days prior to registration) (Note: use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)
-
Total bilirubin =< 1.5 x institutional upper limit of normal (ULN) (within 14 days prior to registration)
-
Aspartate aminotransferase (AST)(serum glutamic-oxaloacetic transaminase [SGOT]) or alanine aminotransferase (ALT)(serum glutamate pyruvate transaminase [SGPT]) =< 3.0 x institutional ULN (within 14 days prior to registration)
-
Serum creatinine =< 1.5 x ULN OR creatinine clearance (CrCl) >= 50 mL/min (if using the Cockcroft-Gault formula) (within 14 days prior to registration)
-
Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial
-
For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated
- Note: Known positive test for hepatitis B virus surface antigen (HBV sAg) indicating acute or chronic infection would make the patient ineligible unless the viral load becomes undetectable on suppressive therapy. Patients who are immune to hepatitis B (anti-hepatitis B surface antibody positive) are eligible (e.g. patients immunized against hepatitis B)
-
Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment for the hepatitis, they are eligible if they have an undetectable HCV viral load.
- Note: Known positive test for hepatitis C virus ribonucleic acid (HCV RNA) indicating acute or chronic infection would make the patient ineligible unless the viral load becomes undetectable on suppressive therapy
-
For women of childbearing potential (WOCBP), negative serum or urine pregnancy test within 24 hours prior to registration
- Women of childbearing potential (WOCBP) is defined as any female who has experienced menarche and who has not undergone surgical sterilization (hysterectomy or bilateral oophorectomy) or who is not postmenopausal. Menopause is defined clinically as 12 months of amenorrhea in a woman over 45 in the absence of other biological or physiological causes. In addition, women under the age of 55 must have a documented serum follicle stimulating hormone (FSH) level less than 40 mIU/mL
-
Women of childbearing potential (WOCBP) and men who are sexually active with WOCBP must be willing to use an adequate method of contraception during and after treatment
-
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
-
Only English, Spanish, or French speaking patients are eligible to participate as these are the only languages for which the mandatory dysphagia-related patient reported instrument (MDADI) is available
Exclusion Criteria:
-
Clinical stages T0; T4; T1-2, N0; or any N2 (AJCC, 8th ed)
-
Recurrent disease
-
Definitive clinical or radiologic evidence of metastatic disease or adenopathy below the clavicles
-
Cancers considered to be from an oral cavity site (oral tongue, floor mouth, alveolar ridge, buccal or lip), or the nasopharynx, hypopharynx, or larynx, even if p16-positive, or histologies of adenosquamous, verrucous, or spindle cell carcinomas
-
Carcinoma of the neck of unknown primary site origin (T0 is ineligible, even if p16-positive)
-
Radiographically matted nodes, defined as 3 abutting nodes with loss of the intervening fat plane
-
Supraclavicular nodes, defined as nodes centered below the level of the cricoid cartilage
-
Gross total excision of both primary and nodal disease; this includes tonsillectomy, local excision of primary site, and nodal excision that removes all clinically and radiographically evident disease. In other words, to participate in this protocol, the patient must have clinically or radiographically evident gross disease for which disease response can be assessed
-
Patients with simultaneous primary cancers or separate bilateral primary tumor sites are excluded with the exception of patients with bilateral tonsil cancers
-
Prior invasive malignancy (except non-melanomatous skin cancer) unless disease free for a minimum of 1095 days (3 years) (of note, the exclusion applies only for invasive cancers such that carcinoma in situ of the breast, oral cavity, or cervix are all permissible)
-
Prior systemic chemotherapy for the study cancer; note that prior chemotherapy for a different cancer is allowable
-
Prior radiotherapy to the region of the study cancer that would result in overlap of radiation therapy fields
-
Prior treatment with an anti-PD-1, anti-PD-L1, anti-PD-L2, anti-CTLA-4 antibody, or any other antibody or drug specifically targeting T-cell co-stimulation or immune checkpoint pathways
-
History of severe hypersensitivity reaction to any monoclonal antibody.
-
Severe, active co-morbidity defined as follows:
- Unstable angina and/or congestive heart failure requiring hospitalization within the last 6 months
- Transmural myocardial infarction within the last 6 months
- Acute bacterial or fungal infection requiring intravenous antibiotics at the time of registration
- Chronic obstructive pulmonary disease exacerbation or other respiratory illness requiring hospitalization or precluding study therapy within 30 days of registration
- Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects
- Acquired immune deficiency syndrome (AIDS) based upon current Centers for Disease Control and Prevention (CDC) definition with immune compromise greater than that noted; note, however, that HIV testing is not required for entry into this protocol. The need to exclude patients with AIDS from this protocol is necessary because the treatments involved in this protocol may be significantly immunosuppressive. Protocol-specific requirements may also exclude immuno-compromised patients
- Condition requiring systemic treatment with either corticosteroids (> 10 mg daily prednisone equivalents) or other immunosuppressive medications within 14 days of registration. Inhaled or topical steroids and adrenal replacement doses < 10 mg daily prednisone equivalents are permitted in the absence of active autoimmune disease
- Patients with active autoimmune disease requiring systemic treatment (i.e. disease modifying agents, corticosteroids, or immunosuppressive drugs) should be excluded. These include but are not limited to patients with a history of immune related neurologic disease, multiple sclerosis, autoimmune (demyelinating) neuropathy, Guillain-Barre syndrome, myasthenia gravis; systemic autoimmune disease such as systemic lupus erythematosus (SLE), rheumatoid arthritis, connective tissue diseases, scleroderma, inflammatory bowel disease (IBD), Crohn's, ulcerative colitis, hepatitis; and patients with a history of toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome, or phospholipid syndrome should be excluded because of the risk of recurrence or exacerbation of disease
- Note: Patients are permitted to enroll if they have vitiligo, type I diabetes mellitus, residual hypothyroidism due to autoimmune condition only requiring hormone replacement, psoriasis not requiring systemic treatment, or conditions not expected to recur in the absence of an external trigger (precipitating event)
-
Patients who are pregnant, nursing, or expecting to conceive or father children
-
Prior allergic reaction to cisplatin
Plan studiów
Jak projektuje się badanie?
Szczegóły projektu
- Główny cel: Leczenie
- Przydział: Randomizowane
- Model interwencyjny: Przydział równoległy
- Maskowanie: Brak (otwarta etykieta)
Broń i interwencje
Grupa uczestników / Arm |
Interwencja / Leczenie |
|---|---|
|
Aktywny komparator: Arm I (Standard RT + cisplatin)
Patients undergo standard dose RT as 70 Gy IMRT or IGRT over 6 fractions per week and receive 100 mg/m^2/day cisplatin IV over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study. |
Ancillary studies
Inne nazwy:
Given IV
Inne nazwy:
Undergo blood sample collection
Inne nazwy:
Undergo CT
Inne nazwy:
Undergo MRI
Inne nazwy:
Ancillary studies Undergo PET
Inne nazwy:
Undergo IMRT
Inne nazwy:
Receive FDG
Inne nazwy:
Undergo tissue biopsy
Inne nazwy:
Undergo IGRT
Inne nazwy:
|
|
Eksperymentalny: Arm II (Reduced RT + cisplatin)
Patients undergo reduced dose RT as 60 Gy IMRT or IGRT QD over 5 fractions per week and receive 100 mg/m^2/day cisplatin IV over 30-60 minutes on days 1 and 22. Treatment continues for 6 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study. |
Ancillary studies
Inne nazwy:
Given IV
Inne nazwy:
Undergo blood sample collection
Inne nazwy:
Undergo CT
Inne nazwy:
Undergo MRI
Inne nazwy:
Ancillary studies Undergo PET
Inne nazwy:
Undergo IMRT
Inne nazwy:
Receive FDG
Inne nazwy:
Undergo tissue biopsy
Inne nazwy:
Undergo IGRT
Inne nazwy:
|
|
Eksperymentalny: Arm III (Reduced RT + nivolumab)
Beginning 1 week prior to radiation, patients receive 240 mg fixed dose nivolumab IV over 30 minutes on day 1. Treatment repeats every 2 weeks (14 days) for up to 6 cycles in the absence of disease progression or unacceptable toxicity. Patients also undergo reduced dose RT as 60 Gy IMRT or IGRT over 6 fractions per week for 5 weeks in the absence of disease progression or unacceptable toxicity. Patients receive FDG and undergo PET/CT or CT during screening and during follow up, and undergo MRI during follow up. Patients may also undergo tissue biopsy and blood sample collection throughout the study. |
Ancillary studies
Inne nazwy:
Undergo blood sample collection
Inne nazwy:
Undergo CT
Inne nazwy:
Ancillary studies Undergo PET
Inne nazwy:
Given IV
Inne nazwy:
Undergo IMRT
Inne nazwy:
Receive FDG
Inne nazwy:
Undergo tissue biopsy
Inne nazwy:
Undergo IGRT
Inne nazwy:
|
Co mierzy badanie?
Podstawowe miary wyniku
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Progression-free Survival (PFS) (Phase II) (Percentage of Participants Alive Without Progression)
Ramy czasowe: From randomization to first progression or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
Progression is defined as local-regional progression or recurrence, distant metastasis, death due to any reason, salvage surgery of primary with tumor present/unknown, salvage neck dissection with tumor present/unknown, > 20 weeks from end of radiation therapy. Progression-free survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis. The primary phase IIR endpoint is tested using a confidence interval (CI) approach with each experimental arm compared to the standard arm (Arm 1). |
From randomization to first progression or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
|
Progression-free Survival (Phase III) (Percentage of Participants Alive Without Progression)
Ramy czasowe: From randomization to first progression or last follow-up. Maximum follow-up was 4.6 years.
|
Progression is defined as local-regional progression or recurrence, distant metastasis, death due to any reason, salvage surgery of primary with tumor present/unknown, salvage neck dissection with tumor present/unknown, > 20 weeks from end of radiation therapy. Progression-free survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis. |
From randomization to first progression or last follow-up. Maximum follow-up was 4.6 years.
|
|
MD Anderson Dysphagia Inventory (MDADI) Global Quality of Life (QOL) Score
Ramy czasowe: Baseline to two years
|
The M. D. Anderson Dysphagia Inventory (MDADI) assesses how patients view their swallowing ability as a result of treatment and how this affects their QOL. It consists of a global quality of life question and a functional, emotional, and physical subscale. The global QOL question ranges from 1 to 5 and multiplied by 20 to obtain a score with a range of 0 to 100. Higher scores indicate better functioning. |
Baseline to two years
|
Miary wyników drugorzędnych
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Locoregional Failure (Percentage of Participants With Locoregional Failure)
Ramy czasowe: From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
Locoregional failure is defined as local-regional progression or recurrence, death due to study cancer or unknown causes, salvage neck dissection with tumor present/unknown. Locoregional failure rates are estimated the cumulative incidence method, treating distant metastasis and death due to any reason other than study cancer or unknown as competing risks, and otherwise censoring participants alive at time of analysis. Each experimental arm is compared to the standard arm (Arm I). |
From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
|
Distant Failure (Percentage of Participants With Distant Failure)
Ramy czasowe: From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
Distant failure is defined as the occurrence of distant metastasis. Distant failure rates are estimated the cumulative incidence method, treating local-regional progression or recurrence, death due to any reason, salvage neck dissection with tumor present/unknown as competing risks, and otherwise censoring participants alive at time of analysis. Each experimental arm is compared to the standard arm (Arm I). |
From randomization to first failure, competing event, or last known follow-up, whichever occurs first. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
|
Overall Survival (Percentage of Participants Alive)
Ramy czasowe: From randomization to death from any cause or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
Survival rates are estimated using the Kaplan-Meier method, censoring participants alive at time of analysis. |
From randomization to death from any cause or last follow-up. Maximum follow-up at the time of analysis was 4.6 years. The 1- and 2-year estimates are reported.
|
|
Number of Participants by Highest Grade Adverse Event Reported
Ramy czasowe: From randomization to last known follow-up. Maximum follow-up at the time of analysis was 4.6 years.
|
Common Terminology Criteria for Adverse Events (CTCAE) version 5.0 grades adverse event severity as follows: 1 = mild, 2 = moderate, 3 = severe, 4 = life-threatening, 5 = death related to adverse event. Summary data is provided in this outcome measure; see Adverse Events Module for specific adverse event data. |
From randomization to last known follow-up. Maximum follow-up at the time of analysis was 4.6 years.
|
|
Hearing
Ramy czasowe: Baseline up to 24 months from end of radiation therapy (RT)
|
Measured as Hearing Handicap Inventory for Adults-Screening (HHIA-S). |
Baseline up to 24 months from end of radiation therapy (RT)
|
|
Quality of Life
Ramy czasowe: Baseline up to 24 months from end of RT
|
Measured by the European Organization for Research and Treatment of Cancer (EORTC)-Quality of Life Questionnaire (QLQ)30. |
Baseline up to 24 months from end of RT
|
|
Fludeoxyglucose F-18 (FDG)-Positron Emission Tomography (PET)/Computed Tomography (CT) Locoregional Control
Ramy czasowe: Up to 6 years
|
Will be associated with PFS. |
Up to 6 years
|
|
Negative Predictive Value of Post-RT FDG-PET/CT for Locoregional Control
Ramy czasowe: At 1 and 2 years
|
The negative predictive value of FDG-PET/CT for locoregional control will be estimated using binomial proportions and confidence intervals based on normal approximation. |
At 1 and 2 years
|
|
Negative Predictive Value of Post-RT FDG-PET/CT for PFS
Ramy czasowe: At 1 and 2 years
|
The negative predictive value of FDG-PET/CT PFS will be estimated using binomial proportions and confidence intervals based on normal approximation. |
At 1 and 2 years
|
|
Incidence of Adverse Events
Ramy czasowe: Up to 6 years
|
Measured using Patient-Reported Outcomes (PRO)-CTCAE. For each symptom, counts and frequencies will be provided for the worst score experienced by the patient by treatment arm. The proportion of patients with scores >= 1 and >= 3 will be compared between groups using a Chi-square test, or Fisher's exact test if cell frequencies are < 5, using a significance level of 0.05. Analysis of changes in patient reported outcomes over time will analyzed by fitting generalized estimating equations (GEE) models using a logit link (dichotomizing the symptom scores as 0 vs. > 1 and 0-2 vs. 3-4) with time of assessment, treatment arm, and treatment-by-time interaction terms in the model. |
Up to 6 years
|
Inne miary wyników
Miara wyniku |
Opis środka |
Ramy czasowe |
|---|---|---|
|
Quality of Life
Ramy czasowe: Baseline up to 24 months from end of RT
|
Measured by EuroQol-5 Dimensional- 5 Level (EQ-5D-5L). |
Baseline up to 24 months from end of RT
|
|
Swallowing Physiology
Ramy czasowe: Up to 6 years
|
Measured by a Modified Barium Swallow (MBS) test. The proportion of aspiration for each arm will be estimated assuming a binomial distribution and between arm comparison will be performed using a Fisher's exact test. |
Up to 6 years
|
|
Locoregional Control for Patients With Post-RT FDG-PET/CT
Ramy czasowe: At 12-14 weeks post-RT
|
Locoregional control rates will be compared between negative and positive/undetermined patients. Cox proportional hazards models will be used to determine whether there are differences between these two groups, while adjusting for treatment arm and other covariates (cause-specific Cox models for locoregional failure). |
At 12-14 weeks post-RT
|
|
PFS for Patients With Post-RT FDG-PET/CT
Ramy czasowe: At 12-14 weeks post-RT
|
PFS rates will be compared between negative and positive/undetermined patients. Cox proportional hazards models will be used to determine whether there are differences between these two groups, while adjusting for treatment arm and other covariates (cause-specific Cox models for locoregional failure). |
At 12-14 weeks post-RT
|
Współpracownicy i badacze
Sponsor
Śledczy
- Główny śledczy: Sue S Yom, NRG Oncology
Daty zapisu na studia
Główne daty studiów
Rozpoczęcie studiów (Rzeczywisty)
Zakończenie podstawowe (Rzeczywisty)
Ukończenie studiów (Szacowany)
Daty rejestracji na studia
Pierwszy przesłany
Pierwszy przesłany, który spełnia kryteria kontroli jakości
Pierwszy wysłany (Rzeczywisty)
Aktualizacje rekordów badań
Ostatnia wysłana aktualizacja (Rzeczywisty)
Ostatnia przesłana aktualizacja, która spełniała kryteria kontroli jakości
Ostatnia weryfikacja
Więcej informacji
Terminy związane z tym badaniem
Dodatkowe istotne warunki MeSH
- Choroby Stomatognatyczne
- Nowotwory według lokalizacji
- Nowotwory
- Nowotwory według typu histologicznego
- Nowotwory głowy i szyi
- Nowotwory gruczołowe i nabłonkowe
- Rak
- Nowotwory, płaskonabłonkowy
- Choroby otorynolaryngologiczne
- Nowotwory gardła
- Nowotwory otorynolaryngologiczne
- Choroby gardła
- Rak płaskonabłonkowy głowy i szyi
- Rak, płaskonabłonkowy
- Nowotwory jamy ustnej i gardła
- Aminokwasy, peptydy i białka
- Białka
- Techniki śledcze
- Lecznictwo
- Techniki laboratoryjne kliniczne
- Techniki i procedury diagnostyczne
- Diagnoza
- Procedury chirurgiczne, operacyjny
- Techniki cytologiczne
- Cytodiagnoza
- Węglowodany
- Przeciwciała, monoklonalne, humanizowane
- Przeciwciała, monoklonalne
- Przeciwciała
- Immunoglobuliny
- Immunoproteiny
- Białka krwi
- Globuliny w surowicy
- Globuliny
- Chemikalia nieorganiczne
- Związki chloru
- Związki azotu
- Elementy
- Metale
- Techniki diagnostyczne, chirurgiczne
- Techniki chemii, analityczne
- Analiza widma
- Metale, ciężkie
- Związki platynowe
- Radioterapia
- Deoksyglukoza
- Cukry deoksy
- Elementy przejściowe
- Radioterapia, zgodna
- Radioterapia, wspomagana komputerowo
- Niwolumab
- Fluorodeoksyglukoza F18
- Cisplatyna
- Cytrynian 1,2-diaminocykloheksanoplatyny II
- Biopsja
- Prowadzenie okazów
- Spektroskopia rezonansu magnetycznego
- Platyna
- Radioterapia, modulowana intensywnością
- Radioterapia, kierowana obrazem
Inne numery identyfikacyjne badania
- NCI-2019-03015
- U10CA180868 (Grant/umowa NIH USA)
- NCI-2019-03015 (Identyfikator rejestru: CTRP (Clinical Trial Reporting Program))
- NRG-HN005 (Inny identyfikator: CTEP)
- NRG-HN005 (Inny identyfikator: NRG Oncology)
Plan dla danych uczestnika indywidualnego (IPD)
Planujesz udostępniać dane poszczególnych uczestników (IPD)?
Opis planu IPD
NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page
Informacje o lekach i urządzeniach, dokumenty badawcze
Bada produkt leczniczy regulowany przez amerykańską FDA
Bada produkt urządzenia regulowany przez amerykańską FDA
Te informacje zostały pobrane bezpośrednio ze strony internetowej clinicaltrials.gov bez żadnych zmian. Jeśli chcesz zmienić, usunąć lub zaktualizować dane swojego badania, skontaktuj się z register@clinicaltrials.gov. Gdy tylko zmiana zostanie wprowadzona na stronie clinicaltrials.gov, zostanie ona automatycznie zaktualizowana również na naszej stronie internetowej .